DE602005019876D1 - Cyclopeptidderivate mit anti-integrin-wirkung - Google Patents

Cyclopeptidderivate mit anti-integrin-wirkung

Info

Publication number
DE602005019876D1
DE602005019876D1 DE602005019876T DE602005019876T DE602005019876D1 DE 602005019876 D1 DE602005019876 D1 DE 602005019876D1 DE 602005019876 T DE602005019876 T DE 602005019876T DE 602005019876 T DE602005019876 T DE 602005019876T DE 602005019876 D1 DE602005019876 D1 DE 602005019876D1
Authority
DE
Germany
Prior art keywords
cyclopeptide derivatives
integrin
effect
integrin effect
cyclopeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005019876T
Other languages
German (de)
English (en)
Inventor
Pozzo Alma Dal
Sergio Penco
Giuseppe Giannini
Maria Ornella Tinti
Claudio Pisano
Loredana Vesci
Ming Hong Ni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of DE602005019876D1 publication Critical patent/DE602005019876D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005019876T 2004-05-13 2005-05-04 Cyclopeptidderivate mit anti-integrin-wirkung Expired - Lifetime DE602005019876D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000239A ITRM20040239A1 (it) 2004-05-13 2004-05-13 Derivati ciclopeptidici ad attivita' antintegrine.
PCT/IT2005/000262 WO2005111064A1 (en) 2004-05-13 2005-05-04 Cyclopeptide derivatives with anti-integrin activity

Publications (1)

Publication Number Publication Date
DE602005019876D1 true DE602005019876D1 (de) 2010-04-22

Family

ID=34968013

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005019876T Expired - Lifetime DE602005019876D1 (de) 2004-05-13 2005-05-04 Cyclopeptidderivate mit anti-integrin-wirkung

Country Status (23)

Country Link
US (1) US20070178045A1 (cg-RX-API-DMAC10.html)
EP (1) EP1751176B1 (cg-RX-API-DMAC10.html)
JP (1) JP2008500971A (cg-RX-API-DMAC10.html)
KR (1) KR20070012524A (cg-RX-API-DMAC10.html)
CN (1) CN1953990A (cg-RX-API-DMAC10.html)
AR (1) AR048957A1 (cg-RX-API-DMAC10.html)
AT (1) ATE460426T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005243418A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0510985A (cg-RX-API-DMAC10.html)
CA (1) CA2562576A1 (cg-RX-API-DMAC10.html)
CY (1) CY1110039T1 (cg-RX-API-DMAC10.html)
DE (1) DE602005019876D1 (cg-RX-API-DMAC10.html)
DK (1) DK1751176T3 (cg-RX-API-DMAC10.html)
ES (1) ES2340862T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20100301T1 (cg-RX-API-DMAC10.html)
IT (1) ITRM20040239A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA06012887A (cg-RX-API-DMAC10.html)
PL (1) PL1751176T3 (cg-RX-API-DMAC10.html)
PT (1) PT1751176E (cg-RX-API-DMAC10.html)
RS (1) RS51300B (cg-RX-API-DMAC10.html)
SI (1) SI1751176T1 (cg-RX-API-DMAC10.html)
TW (1) TW200606178A (cg-RX-API-DMAC10.html)
WO (1) WO2005111064A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2436109T3 (es) * 2006-02-09 2013-12-27 Belrose Pharma Inc. Conjugados poliméricos de múltiples brazos de 7-etil-10-hidroxicamptotecina para el tratamiento del cáncer de mama, del cáncer colorrectal, del cáncer de páncreas, de ovario y de pulmón
EP1961759A1 (en) * 2007-02-21 2008-08-27 Universita'degli Studi Di Milano Integrin targeted cyclopeptide ligands, their preparation and use
TWI474819B (zh) 2012-05-15 2015-03-01 國立成功大學 調控物及含有該調控物之醫藥組合物
JP2016515120A (ja) * 2013-03-15 2016-05-26 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． 抗アルファｖベータ５抗体を用いた急性腎損傷の治療及び予防
CN103588863B (zh) * 2013-11-15 2016-08-17 苏州强耀生物科技有限公司 Rgd环肽合成制备工艺
WO2022183360A1 (en) * 2021-03-02 2022-09-09 Tsao Yeou Ping Short synthetic peptide and their uses for treating dry eye disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5449761A (en) * 1993-09-28 1995-09-12 Cytogen Corporation Metal-binding targeted polypeptide constructs
US6027711A (en) * 1995-06-07 2000-02-22 Rhomed Incorporated Structurally determined metallo-constructs and applications
DE19725368A1 (de) * 1997-06-16 1998-12-17 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren und deren Verwendung für bildgebende Verfahren
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.

Also Published As

Publication number Publication date
RS51300B (sr) 2010-12-31
HRP20100301T1 (hr) 2010-06-30
ES2340862T3 (es) 2010-06-10
WO2005111064A8 (en) 2006-02-09
PT1751176E (pt) 2010-05-12
JP2008500971A (ja) 2008-01-17
SI1751176T1 (sl) 2010-06-30
PL1751176T3 (pl) 2010-08-31
KR20070012524A (ko) 2007-01-25
EP1751176A1 (en) 2007-02-14
CY1110039T1 (el) 2012-05-23
TW200606178A (en) 2006-02-16
AR048957A1 (es) 2006-06-14
ATE460426T1 (de) 2010-03-15
CN1953990A (zh) 2007-04-25
US20070178045A1 (en) 2007-08-02
EP1751176B1 (en) 2010-03-10
DK1751176T3 (da) 2010-06-14
ITRM20040239A1 (it) 2004-08-13
MXPA06012887A (es) 2007-02-15
BRPI0510985A (pt) 2007-12-04
CA2562576A1 (en) 2005-11-24
WO2005111064A1 (en) 2005-11-24
AU2005243418A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
DE502005006888D1 (de) Implantat mit einstückigem Drehgelenk
DK1725553T3 (da) Tetrahydropyridoindolderivater
ATE540935T1 (de) Chinazolinderivate
DK1761541T3 (da) Pyrrazolo-pyrimidin-derivater
DE502005000502D1 (de) Vernetzbare Polyorganosiloxanmassen
ATE417830T1 (de) Sulfonylbenzimidazolderivate
DE602005023231D1 (de) Polyethylengarne
DK2119472T3 (da) Hud-/hårbehandlingssystem
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
DE502005010285D1 (de) Zylinderanordnung mit einstellbarem Anschlag
ATE460426T1 (de) Cyclopeptidderivate mit anti-integrin-wirkung
ATE365731T1 (de) 4-amino-5-cyanopyrimidinderivate
DE502005011345D1 (de) Klappen-anordnung
FI20040569A0 (fi) Tuloilmalaite
EP1799223A4 (en) ARYLTHIOBENZYLPIPERIDINE DERIVATIVES
FR2874618B1 (fr) Super degraissant
DE502005011107D1 (de) Förderzeug mit Anbaugerät
FR2880367B1 (fr) Digue portuaire artificielle
SE0402096L (sv) Klädesplagg
NO20045522A (no) Svivel
FIU20040016U0 (fi) Kiinnityssovitelma
UA9726S (uk) Стілець
UA9721S (uk) Стілець

Legal Events

Date Code Title Description
8364 No opposition during term of opposition